首页 > 最新文献

Current Opinion in Supportive and Palliative Care最新文献

英文 中文
Acute oncology: the care of older patients in the emergency department. 急性肿瘤:急诊科老年患者的护理。
IF 2 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-03-01 Epub Date: 2026-01-27 DOI: 10.1097/SPC.0000000000000789
Jason den Duijn, Christian H Nickel, Tim Cooksley

Purpose of review: There has been a notable rise in cancer-related emergencies, especially in older patients, due to an increase in those undergoing complex therapies. In this review, we consider the management and clinical workup of the older cancer patient in the emergency department (ED). We will reflect on clinical features of older patients with cancer, as well as fall, delirium, febrile neutropenia (FN), and immune checkpoint inhibitor toxicity.

Recent findings: Older patients with cancer are more likely to require admission to hospital following ED attendance. The most common emergency presentations are fever, pain and gastrointestinal symptoms. The complexity of common presentations, such as falls and delirium, is often overlooked in older cancer patients. FN in older patients is associated with increased mortality and a higher likelihood of requiring inpatient care. Despite their therapeutic benefits in older patients, the broad spectrum of immune-related toxicities even at lower grades, can lead to functional decline and the need to discontinue therapy.

Summary: The number of older people with cancer presenting to emergency care is expected to rise. In response to this growing and complex demand, a comprehensive, individualised, and multi-disciplinary approach is essential. Clinicians need to be aware of the increasingly broad spectrum of diagnoses in this population and tailor their assessment and management strategies accordingly.

综述的目的:由于接受复杂治疗的患者增加,癌症相关的紧急情况显著增加,特别是在老年患者中。在这篇综述中,我们考虑在急诊科(ED)老年癌症患者的管理和临床检查。我们将反思老年癌症患者的临床特征,以及跌倒、谵妄、发热性中性粒细胞减少症(FN)和免疫检查点抑制剂毒性。最近的研究发现:老年癌症患者在急诊科就诊后更有可能需要住院。最常见的急诊表现是发烧、疼痛和胃肠道症状。老年癌症患者常见症状的复杂性,如跌倒和谵妄,往往被忽视。老年患者的FN与死亡率增加和需要住院治疗的可能性增加有关。尽管它们对老年患者有治疗效果,但广泛的免疫相关毒性,即使在较低级别,也可能导致功能下降,需要停止治疗。摘要:接受紧急护理的老年癌症患者的数量预计会上升。为了应对这种日益增长和复杂的需求,一个全面的、个性化的、多学科的方法是必不可少的。临床医生需要意识到这一人群的诊断范围越来越广,并相应地调整他们的评估和管理策略。
{"title":"Acute oncology: the care of older patients in the emergency department.","authors":"Jason den Duijn, Christian H Nickel, Tim Cooksley","doi":"10.1097/SPC.0000000000000789","DOIUrl":"10.1097/SPC.0000000000000789","url":null,"abstract":"<p><strong>Purpose of review: </strong>There has been a notable rise in cancer-related emergencies, especially in older patients, due to an increase in those undergoing complex therapies. In this review, we consider the management and clinical workup of the older cancer patient in the emergency department (ED). We will reflect on clinical features of older patients with cancer, as well as fall, delirium, febrile neutropenia (FN), and immune checkpoint inhibitor toxicity.</p><p><strong>Recent findings: </strong>Older patients with cancer are more likely to require admission to hospital following ED attendance. The most common emergency presentations are fever, pain and gastrointestinal symptoms. The complexity of common presentations, such as falls and delirium, is often overlooked in older cancer patients. FN in older patients is associated with increased mortality and a higher likelihood of requiring inpatient care. Despite their therapeutic benefits in older patients, the broad spectrum of immune-related toxicities even at lower grades, can lead to functional decline and the need to discontinue therapy.</p><p><strong>Summary: </strong>The number of older people with cancer presenting to emergency care is expected to rise. In response to this growing and complex demand, a comprehensive, individualised, and multi-disciplinary approach is essential. Clinicians need to be aware of the increasingly broad spectrum of diagnoses in this population and tailor their assessment and management strategies accordingly.</p>","PeriodicalId":48837,"journal":{"name":"Current Opinion in Supportive and Palliative Care","volume":" ","pages":"11-17"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145821774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing FACIT-fatigue and EORTC QLQ-FA12 for assessing the quality of life in people with cancer-related fatigue. 比较FACIT-fatigue和EORTC QLQ-FA12对癌症相关疲劳患者生活质量的评估
IF 2 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-03-01 Epub Date: 2026-01-27 DOI: 10.1097/SPC.0000000000000791
Britney Zhang, Amari Randhawa, Ayush Patel, Eduardo Bruera, Nicolas H Hart, Andrew Bottomley, David Cella, Muna Al-Khaifi, Partha Patel, Edward Chow, Henry C Y Wong

Purpose of review: Two common quality of life (QoL) questionnaires for cancer-related fatigue (CRF) are the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Fatigue 12 (QLQ-FA12) and Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue). This systematic review compared their content, validity, and psychometric properties.

Recent findings: Twenty-four studies were included. The QLQ-FA12 (12 items) provides physical, emotional, and cognitive subscales, while the FACIT-Fatigue (13 items) captures self-reported fatigue and its impact on daily function. Both instruments demonstrated validity, internal consistency, test-retest reliability, and sensitivity. Construct validity was supported by correlations with QoL and physical-function measures, and confirmatory factor analyses upheld their intended dimensional structures. The QLQ-FA12's 4-point question format offers distinct domain scores, whereas the FACIT-Fatigue's 5-point statement format yields a single total score. The QLQ-FA12 is preferred when a multidimensional profile is needed, such as in trials addressing specific fatigue drivers or pairing with QLQ-C30 domains. The FACIT-Fatigue suits brief screening or large-scale studies where efficiency and a single total fatigue score are priorities.

Summary: The EORTC QLQ-FA12 and FACIT-Fatigue are both sufficiently validated for assessing CRF-related QoL. The QLQ-FA12 is more appropriate when a multidimensional profile is required, whereas FACIT-Fatigue suits contexts needing a unidimensional total severity score.

回顾目的:两种常见的癌症相关疲劳(CRF)生活质量(QoL)问卷是欧洲癌症研究与治疗组织(EORTC)生活质量问卷疲劳12 (QLQ-FA12)和慢性疾病治疗-疲劳功能评估(facit -疲劳)。本系统综述比较了它们的内容、效度和心理测量特性。最新发现:包括24项研究。QLQ-FA12(12个项目)提供了身体、情绪和认知的子量表,而facit -疲劳(13个项目)捕获了自我报告的疲劳及其对日常功能的影响。两种仪器都证明了有效性、内部一致性、重测信度和灵敏度。建构效度与生活质量和身体功能测量的相关性支持,验证性因子分析支持其预期的维度结构。QLQ-FA12的4分题格式提供了不同的领域分数,而FACIT-Fatigue的5分题格式产生了单一的总分。当需要多维轮廓时,例如在处理特定疲劳驱动因素或与QLQ-C30域配对的试验中,QLQ-FA12是首选。FACIT-Fatigue适用于效率和单一总疲劳评分优先的简短筛选或大规模研究。总结:EORTC QLQ-FA12和FACIT-Fatigue都被充分验证用于评估crf相关的生活质量。当需要多维概况时,QLQ-FA12更合适,而FACIT-Fatigue适合需要一维总严重性评分的上下文。
{"title":"Comparing FACIT-fatigue and EORTC QLQ-FA12 for assessing the quality of life in people with cancer-related fatigue.","authors":"Britney Zhang, Amari Randhawa, Ayush Patel, Eduardo Bruera, Nicolas H Hart, Andrew Bottomley, David Cella, Muna Al-Khaifi, Partha Patel, Edward Chow, Henry C Y Wong","doi":"10.1097/SPC.0000000000000791","DOIUrl":"10.1097/SPC.0000000000000791","url":null,"abstract":"<p><strong>Purpose of review: </strong>Two common quality of life (QoL) questionnaires for cancer-related fatigue (CRF) are the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Fatigue 12 (QLQ-FA12) and Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue). This systematic review compared their content, validity, and psychometric properties.</p><p><strong>Recent findings: </strong>Twenty-four studies were included. The QLQ-FA12 (12 items) provides physical, emotional, and cognitive subscales, while the FACIT-Fatigue (13 items) captures self-reported fatigue and its impact on daily function. Both instruments demonstrated validity, internal consistency, test-retest reliability, and sensitivity. Construct validity was supported by correlations with QoL and physical-function measures, and confirmatory factor analyses upheld their intended dimensional structures. The QLQ-FA12's 4-point question format offers distinct domain scores, whereas the FACIT-Fatigue's 5-point statement format yields a single total score. The QLQ-FA12 is preferred when a multidimensional profile is needed, such as in trials addressing specific fatigue drivers or pairing with QLQ-C30 domains. The FACIT-Fatigue suits brief screening or large-scale studies where efficiency and a single total fatigue score are priorities.</p><p><strong>Summary: </strong>The EORTC QLQ-FA12 and FACIT-Fatigue are both sufficiently validated for assessing CRF-related QoL. The QLQ-FA12 is more appropriate when a multidimensional profile is required, whereas FACIT-Fatigue suits contexts needing a unidimensional total severity score.</p>","PeriodicalId":48837,"journal":{"name":"Current Opinion in Supportive and Palliative Care","volume":" ","pages":"52-61"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145851204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Defining thresholds for meaningful interpretation of patient-reported outcome scores. 定义有意义解释患者报告的结果评分的阈值。
IF 2 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-03-01 Epub Date: 2026-01-27 DOI: 10.1097/SPC.0000000000000788
Kim Cocks, Johannes M Giesinger

Purpose of review: There are many different patient-reported outcome measures to assess how patients feel or function but they vary in how they collect responses and score results. Therefore, it can be hard to know what a change in score means for a patient or whether treatments compared in a trial result in different patient experiences. Methods exist to estimate thresholds to aid interpretation, but no single method is considered the best. This review considers recent advances in efforts to improve these methods.

Recent findings: New research has been published on the choice of appropriate anchors and the methods to establish thresholds based on them. There has been increased focus on the derivation of thresholds used to compare scores between groups of patients versus those used to interpret an individual's change in scores over time. Studies are also highlighting how baseline severity and other factors affect how we estimate thresholds.

Summary: Consensus on the optimal methods for the derivation of score interpretation thresholds is still required, although the field continues to grow in understanding biases and impacts of treatment and population factors on estimation.

综述目的:有许多不同的患者报告的结果测量来评估患者的感觉或功能,但它们在如何收集反应和评分结果方面各不相同。因此,很难知道评分的变化对患者意味着什么,或者在试验中比较的治疗是否会导致不同的患者体验。存在一些方法来估计阈值以帮助解释,但没有一种方法被认为是最好的。本综述考虑了改进这些方法的最新进展。最新发现:关于选择合适的锚点和基于它们建立阈值的方法的新研究已经发表。人们越来越关注用于比较患者组之间分数的阈值的推导,而不是用于解释个体分数随时间变化的阈值。研究还强调了基线严重性和其他因素如何影响我们对阈值的估计。摘要:尽管该领域在理解偏差以及治疗和人口因素对估计的影响方面不断发展,但仍然需要就推导分数解释阈值的最佳方法达成共识。
{"title":"Defining thresholds for meaningful interpretation of patient-reported outcome scores.","authors":"Kim Cocks, Johannes M Giesinger","doi":"10.1097/SPC.0000000000000788","DOIUrl":"10.1097/SPC.0000000000000788","url":null,"abstract":"<p><strong>Purpose of review: </strong>There are many different patient-reported outcome measures to assess how patients feel or function but they vary in how they collect responses and score results. Therefore, it can be hard to know what a change in score means for a patient or whether treatments compared in a trial result in different patient experiences. Methods exist to estimate thresholds to aid interpretation, but no single method is considered the best. This review considers recent advances in efforts to improve these methods.</p><p><strong>Recent findings: </strong>New research has been published on the choice of appropriate anchors and the methods to establish thresholds based on them. There has been increased focus on the derivation of thresholds used to compare scores between groups of patients versus those used to interpret an individual's change in scores over time. Studies are also highlighting how baseline severity and other factors affect how we estimate thresholds.</p><p><strong>Summary: </strong>Consensus on the optimal methods for the derivation of score interpretation thresholds is still required, although the field continues to grow in understanding biases and impacts of treatment and population factors on estimation.</p>","PeriodicalId":48837,"journal":{"name":"Current Opinion in Supportive and Palliative Care","volume":" ","pages":"18-23"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Driving innovation in cancer symptom science through translational research: bridging science and practice. 通过转化研究推动癌症症状科学的创新:连接科学与实践。
IF 2 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-03-01 Epub Date: 2026-01-27 DOI: 10.1097/SPC.0000000000000792
Juan J Fierro, Seamus Coyle, Barry J A Laird, Lia van Zuylen

Purpose of review: Translational research is a dynamic process that aims to apply fundamental scientific discoveries into clinical practice through strong cooperation between scientists and healthcare providers. This review discusses recent advances in symptom science within palliative care, driven by translational research, and highlights the pressing need to bridge the gap between scientific innovation and clinical practice.

Recent findings: The dramatic change in the cancer landscape in the last decade has been achieved through translational research. However, the role of translational research in symptom science in palliative care for patients with cancer has been chronically neglected. Recently, initial progress has been made in symptom prediction through biomarker discovery for distressing syndromes, such as delirium or cancer-related cachexia. Other areas where translational approaches offer promise include predicting survival and identifying the dying phase in patients with advanced cancer.

Summary: Despite some progress in introducing translational research into palliative care, significant challenges persist, limiting the full potential of integrative and collaborative research to improve patient outcomes in cancer palliative care. Herein, key areas are discussed, including emerging themes and tools that could help bridge this gap.

综述目的:转化研究是一个动态的过程,旨在通过科学家和医疗保健提供者之间的紧密合作,将基础科学发现应用于临床实践。这篇综述讨论了在转译研究的推动下,姑息治疗中症状科学的最新进展,并强调了弥合科学创新与临床实践之间差距的迫切需要。最近的发现:在过去十年中,癌症领域的巨大变化是通过转化研究实现的。然而,症状科学转化研究在癌症患者姑息治疗中的作用一直被忽视。最近,通过发现生物标志物来预测痛苦综合征(如谵妄或癌症相关恶病质)的症状取得了初步进展。转化方法提供前景的其他领域包括预测晚期癌症患者的生存和确定死亡阶段。摘要:尽管在将转化研究引入姑息治疗方面取得了一些进展,但重大挑战仍然存在,限制了综合和合作研究的全部潜力,以改善癌症姑息治疗的患者预后。本文讨论了关键领域,包括有助于弥合这一差距的新兴主题和工具。
{"title":"Driving innovation in cancer symptom science through translational research: bridging science and practice.","authors":"Juan J Fierro, Seamus Coyle, Barry J A Laird, Lia van Zuylen","doi":"10.1097/SPC.0000000000000792","DOIUrl":"10.1097/SPC.0000000000000792","url":null,"abstract":"<p><strong>Purpose of review: </strong>Translational research is a dynamic process that aims to apply fundamental scientific discoveries into clinical practice through strong cooperation between scientists and healthcare providers. This review discusses recent advances in symptom science within palliative care, driven by translational research, and highlights the pressing need to bridge the gap between scientific innovation and clinical practice.</p><p><strong>Recent findings: </strong>The dramatic change in the cancer landscape in the last decade has been achieved through translational research. However, the role of translational research in symptom science in palliative care for patients with cancer has been chronically neglected. Recently, initial progress has been made in symptom prediction through biomarker discovery for distressing syndromes, such as delirium or cancer-related cachexia. Other areas where translational approaches offer promise include predicting survival and identifying the dying phase in patients with advanced cancer.</p><p><strong>Summary: </strong>Despite some progress in introducing translational research into palliative care, significant challenges persist, limiting the full potential of integrative and collaborative research to improve patient outcomes in cancer palliative care. Herein, key areas are discussed, including emerging themes and tools that could help bridge this gap.</p>","PeriodicalId":48837,"journal":{"name":"Current Opinion in Supportive and Palliative Care","volume":" ","pages":"45-51"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12851542/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145999344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practical aspects of managing multimorbidity in older adults with cancer. 老年癌症患者多病管理的实践方面。
IF 2 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-03-01 Epub Date: 2026-01-27 DOI: 10.1097/SPC.0000000000000790
Shane O'Hanlon, Mark Baxter, Gabor Liposits

Purpose of review: Managing multimorbidity in older adults with cancer is a central, complex challenge in modern oncology. Historically, this population was underrepresented in clinical trials, leaving clinicians without practical guidance. This review synthesizes recent evidence that moves beyond simply documenting frailty to deploying targeted, evidence-based interventions to improve supportive and palliative care.

Recent findings: The literature supports a practical 2-step approach to assessment, using screening tools like the Geriatric-8 to trigger a full Comprehensive Geriatric Assessment (CGA) with management, which is proven to reduce treatment toxicity. Goal-aligned deprescribing has emerged as an active clinical skill to manage polypharmacy. In decision-making, the focus has shifted from guideline-concordant to goal-concordant care. Finally, a needs-based paradigm for integrating palliative care is replacing older, prognosis-based models, distinguishing between generalist skills for all clinicians and specialist consultation for complex cases.

Summary: Recent evidence provides clinicians with practical approaches. By using validated screening, CGA-led interventions, systematic deprescribing, and needs-based palliative care, clinical teams can reduce treatment toxicity, lessen medication burden, and align complex cancer care with the personal priorities and quality-of-life goals of older patients.

综述目的:管理老年癌症患者的多病是现代肿瘤学的一个核心、复杂的挑战。从历史上看,这一人群在临床试验中的代表性不足,使临床医生缺乏实际指导。本综述综合了最近的证据,这些证据超越了简单地记录脆弱性,转而部署有针对性的、基于证据的干预措施,以改善支持性和姑息治疗。最近的发现:文献支持一种实用的两步评估方法,使用筛选工具,如Geriatric-8,与管理层一起触发全面的老年综合评估(CGA),这已被证明可以减少治疗毒性。目标一致的处方描述已经成为管理多药的一种积极的临床技能。在决策过程中,关注的焦点已经从指导方针一致性转向目标一致性。最后,以需求为基础的姑息治疗整合模式正在取代旧的、以预后为基础的模式,区分所有临床医生的通才技能和复杂病例的专家咨询。摘要:最近的证据为临床医生提供了实用的方法。通过使用经过验证的筛查、cga主导的干预措施、系统的处方处方和基于需求的姑息治疗,临床团队可以降低治疗毒性,减轻药物负担,并将复杂的癌症治疗与老年患者的个人优先事项和生活质量目标相结合。
{"title":"Practical aspects of managing multimorbidity in older adults with cancer.","authors":"Shane O'Hanlon, Mark Baxter, Gabor Liposits","doi":"10.1097/SPC.0000000000000790","DOIUrl":"10.1097/SPC.0000000000000790","url":null,"abstract":"<p><strong>Purpose of review: </strong>Managing multimorbidity in older adults with cancer is a central, complex challenge in modern oncology. Historically, this population was underrepresented in clinical trials, leaving clinicians without practical guidance. This review synthesizes recent evidence that moves beyond simply documenting frailty to deploying targeted, evidence-based interventions to improve supportive and palliative care.</p><p><strong>Recent findings: </strong>The literature supports a practical 2-step approach to assessment, using screening tools like the Geriatric-8 to trigger a full Comprehensive Geriatric Assessment (CGA) with management, which is proven to reduce treatment toxicity. Goal-aligned deprescribing has emerged as an active clinical skill to manage polypharmacy. In decision-making, the focus has shifted from guideline-concordant to goal-concordant care. Finally, a needs-based paradigm for integrating palliative care is replacing older, prognosis-based models, distinguishing between generalist skills for all clinicians and specialist consultation for complex cases.</p><p><strong>Summary: </strong>Recent evidence provides clinicians with practical approaches. By using validated screening, CGA-led interventions, systematic deprescribing, and needs-based palliative care, clinical teams can reduce treatment toxicity, lessen medication burden, and align complex cancer care with the personal priorities and quality-of-life goals of older patients.</p>","PeriodicalId":48837,"journal":{"name":"Current Opinion in Supportive and Palliative Care","volume":" ","pages":"5-10"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145851182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the EORTC QLQ PR25 and the FACT-P for assessing quality of life in patients with prostate cancer - an updated literature review. 评价前列腺癌患者生活质量的EORTC QLQ PR25和FACT-P的比较——最新文献综述
IF 2 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-03-01 Epub Date: 2026-01-27 DOI: 10.1097/SPC.0000000000000786
David Chen, Jane Jomy, Tony Ning, Samantha Cheng, Maira Khan, Andrew Bottomley, David Cella, Hans Chung, Shin Fung Lee, Urban Emmenegger, Amanda Hird, Edward Chow, Henry C Y Wong, Srinivas Raman

Purpose of review: Prostate cancer can significantly impact psychological, physical, and social well-being. This systematic review compares the development of the Functional Assessment of Cancer Therapy-Prostate (FACT-P) and the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Prostate Cancer (EORTC QLQ-PR25) for evaluating quality of life (QoL) in prostate cancer patients, focusing on development, characteristics, reliability, validity, and psychometric properties.

Recent findings: Thirteen studies published between 2013 and 2022 met the inclusion criteria. FACT-P and EORTC QLQ-PR25 are both validated, reliable, and responsive instruments for assessing QoL in prostate cancer patients. FACT-P emphasizes emotional, social, and functional well-being alongside prostate-specific concerns, while EORTC QLQ-PR25 focuses on prostate-specific symptoms, particularly urinary, sexual, and hormonal function.

Summary: The FACT-P and EORTC QLQ-PR25 are valid tools for assessing QoL in prostate cancer patients. The decision to use the FACT-P or the EORTC QLQ-PR25 instrument may depend on the population and aims of the proposed study. Given substantial advancements in treatment and patient care in prostate cancer since the initial development of the FACT-P and EORTC QLQ-PR25, these quality of life instruments should undergo comprehensive validation to ensure they remain a relevant and effective tool for contemporary prostate cancer clinical trials.

综述目的:前列腺癌可以显著影响心理、生理和社会健康。本系统综述比较了前列腺癌治疗功能评估(FACT-P)和欧洲癌症研究与治疗组织前列腺癌生活质量问卷(EORTC QLQ-PR25)的发展,以评估前列腺癌患者的生活质量(QoL),重点是发展,特征,信度,效度和心理测量特性。最新发现:2013年至2022年间发表的13项研究符合纳入标准。FACT-P和EORTC QLQ-PR25都是评估前列腺癌患者生活质量的有效、可靠和反应灵敏的工具。FACT-P强调情感、社交和功能健康以及前列腺特异性问题,而EORTC QLQ-PR25侧重于前列腺特异性症状,特别是泌尿、性和激素功能。FACT-P和EORTC QLQ-PR25是评估前列腺癌患者生活质量的有效工具。使用FACT-P或EORTC QLQ-PR25仪器的决定可能取决于拟议研究的人群和目的。自FACT-P和EORTC QLQ-PR25最初开发以来,前列腺癌的治疗和患者护理取得了实质性进展,这些生活质量仪器应该经过全面的验证,以确保它们仍然是当代前列腺癌临床试验的相关和有效工具。
{"title":"Comparison of the EORTC QLQ PR25 and the FACT-P for assessing quality of life in patients with prostate cancer - an updated literature review.","authors":"David Chen, Jane Jomy, Tony Ning, Samantha Cheng, Maira Khan, Andrew Bottomley, David Cella, Hans Chung, Shin Fung Lee, Urban Emmenegger, Amanda Hird, Edward Chow, Henry C Y Wong, Srinivas Raman","doi":"10.1097/SPC.0000000000000786","DOIUrl":"https://doi.org/10.1097/SPC.0000000000000786","url":null,"abstract":"<p><strong>Purpose of review: </strong>Prostate cancer can significantly impact psychological, physical, and social well-being. This systematic review compares the development of the Functional Assessment of Cancer Therapy-Prostate (FACT-P) and the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Prostate Cancer (EORTC QLQ-PR25) for evaluating quality of life (QoL) in prostate cancer patients, focusing on development, characteristics, reliability, validity, and psychometric properties.</p><p><strong>Recent findings: </strong>Thirteen studies published between 2013 and 2022 met the inclusion criteria. FACT-P and EORTC QLQ-PR25 are both validated, reliable, and responsive instruments for assessing QoL in prostate cancer patients. FACT-P emphasizes emotional, social, and functional well-being alongside prostate-specific concerns, while EORTC QLQ-PR25 focuses on prostate-specific symptoms, particularly urinary, sexual, and hormonal function.</p><p><strong>Summary: </strong>The FACT-P and EORTC QLQ-PR25 are valid tools for assessing QoL in prostate cancer patients. The decision to use the FACT-P or the EORTC QLQ-PR25 instrument may depend on the population and aims of the proposed study. Given substantial advancements in treatment and patient care in prostate cancer since the initial development of the FACT-P and EORTC QLQ-PR25, these quality of life instruments should undergo comprehensive validation to ensure they remain a relevant and effective tool for contemporary prostate cancer clinical trials.</p>","PeriodicalId":48837,"journal":{"name":"Current Opinion in Supportive and Palliative Care","volume":"20 1","pages":"33-44"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146087718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating geriatric assessment across the cancer continuum. 整合整个癌症连续体的老年评估。
IF 2 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-03-01 Epub Date: 2026-01-27 DOI: 10.1097/SPC.0000000000000796
Schroder Sattar, Christopher Steer
{"title":"Integrating geriatric assessment across the cancer continuum.","authors":"Schroder Sattar, Christopher Steer","doi":"10.1097/SPC.0000000000000796","DOIUrl":"https://doi.org/10.1097/SPC.0000000000000796","url":null,"abstract":"","PeriodicalId":48837,"journal":{"name":"Current Opinion in Supportive and Palliative Care","volume":"20 1","pages":"1-4"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146087763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation of electronic patient-reported outcomes in supportive care for oncology patients. 肿瘤患者支持性护理中电子患者报告结果的实施。
IF 2 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-03-01 Epub Date: 2026-01-27 DOI: 10.1097/SPC.0000000000000793
Luciana Beatriz Mendes Gomes Siqueira, Dylan Callens, Sun Choi, Chahrazad Benazzouz, Xiaoyang Lan, Colleen Dunphy, Doris Howell, Lawson Eng, Eva Oldenburger

Purpose of review: Patient-reported outcomes (PROs) have become increasingly important in oncology, capturing the patient perspective on symptoms, treatment effects, and health-related quality of life. Transitioning to electronic platforms (ePROs) enables real-time monitoring, efficient integration into clinical workflows, and enhanced patient-centered care. This review explores recent evidence on the clinical utility, barriers, and future directions of integrating ePROs in supportive care in oncology.

Recent findings: ePROs improve symptom control, quality of life, engagement, and in some studies, overall survival. They support earlier clinical interventions, reducing emergency visits and hospitalizations and help improve outcomes. Barriers persist at system (infrastructure, interoperability, and data security), clinician (workflow disruption, time constraints, and alert fatigue), and patient (digital literacy, access, and usability) levels. Mitigation strategies include organizational support, clinician champions, codesigned inclusive platforms, and robust privacy safeguards. Emerging opportunities involve integration with artificial intelligence, big data, and decision-support systems to advance precision oncology and population health management.

Summary: ePROs represent a transformative approach in supportive cancer care. Overcoming multilevel barriers and harnessing digital innovations are essential to optimize clinical outcomes, equity, and long-term sustainability.

综述目的:患者报告的预后(pro)在肿瘤学中变得越来越重要,它捕捉了患者对症状、治疗效果和健康相关生活质量的看法。过渡到电子平台(ePROs)可以实现实时监控,有效地集成到临床工作流程中,并增强以患者为中心的护理。这篇综述探讨了将ePROs整合到肿瘤学支持治疗中的临床应用、障碍和未来方向的最新证据。最近的研究发现:ePROs可以改善症状控制、生活质量、参与度,在一些研究中,还可以改善总体生存率。它们支持早期临床干预,减少急诊和住院,并有助于改善结果。障碍仍然存在于系统(基础设施、互操作性和数据安全性)、临床医生(工作流程中断、时间限制和警报疲劳)和患者(数字素养、访问和可用性)层面。缓解策略包括组织支持、临床医生倡导者、共同设计的包容性平台和强大的隐私保护。新兴机遇包括与人工智能、大数据和决策支持系统的整合,以推进精准肿瘤学和人口健康管理。总结:ePROs代表了支持性癌症治疗的一种变革性方法。克服多层次障碍和利用数字创新对于优化临床结果、公平和长期可持续性至关重要。
{"title":"Implementation of electronic patient-reported outcomes in supportive care for oncology patients.","authors":"Luciana Beatriz Mendes Gomes Siqueira, Dylan Callens, Sun Choi, Chahrazad Benazzouz, Xiaoyang Lan, Colleen Dunphy, Doris Howell, Lawson Eng, Eva Oldenburger","doi":"10.1097/SPC.0000000000000793","DOIUrl":"10.1097/SPC.0000000000000793","url":null,"abstract":"<p><strong>Purpose of review: </strong>Patient-reported outcomes (PROs) have become increasingly important in oncology, capturing the patient perspective on symptoms, treatment effects, and health-related quality of life. Transitioning to electronic platforms (ePROs) enables real-time monitoring, efficient integration into clinical workflows, and enhanced patient-centered care. This review explores recent evidence on the clinical utility, barriers, and future directions of integrating ePROs in supportive care in oncology.</p><p><strong>Recent findings: </strong>ePROs improve symptom control, quality of life, engagement, and in some studies, overall survival. They support earlier clinical interventions, reducing emergency visits and hospitalizations and help improve outcomes. Barriers persist at system (infrastructure, interoperability, and data security), clinician (workflow disruption, time constraints, and alert fatigue), and patient (digital literacy, access, and usability) levels. Mitigation strategies include organizational support, clinician champions, codesigned inclusive platforms, and robust privacy safeguards. Emerging opportunities involve integration with artificial intelligence, big data, and decision-support systems to advance precision oncology and population health management.</p><p><strong>Summary: </strong>ePROs represent a transformative approach in supportive cancer care. Overcoming multilevel barriers and harnessing digital innovations are essential to optimize clinical outcomes, equity, and long-term sustainability.</p>","PeriodicalId":48837,"journal":{"name":"Current Opinion in Supportive and Palliative Care","volume":" ","pages":"24-32"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145999371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient-reported and patient experience outcome tools for palliative care in acute hospitals - What's helpful? What are we missing? 急性医院姑息治疗的患者报告和患者体验结果工具-有什么帮助?我们错过了什么?
IF 2 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-01 Epub Date: 2025-10-28 DOI: 10.1097/SPC.0000000000000785
Bridget Johnston, Muzeyyen Seckin, Alison Brown

Purpose of the review: The primary aim of this review was to identify and describe the tools or methods used to capture patient-reported experiences and outcomes related to palliative care provided within acute hospital settings.

Recent findings: Twenty-eight patient-reported outcome and experience measures were used across the studies. The studies mainly used the patient-reported outcome measures to assess symptom burden and distress. Only four studies used both patient-reported outcome measures and patient-reported experience measures. Most studies predominantly included patients with cancer. Only one new measure was found in the last 18 months. There was lack of use of electronic versions of patient-reported outcome and experience measures in inpatient palliative care.

Summary: Limited evidence was found on the use of electronic version of patient-reported outcome and patient reported experience measures in inpatient palliative care. There is a critical need to enhance understanding and routine implementation of more holistic patient-reported outcome measures in hospital-based specialist palliative care. Further research is needed to identify the most appropriate electronic version of holistic patient-reported outcome measures and patient-reported experience measures for use in these settings.

综述的目的:本综述的主要目的是确定和描述用于捕获患者报告的与急性医院环境中提供的姑息治疗相关的经验和结果的工具或方法。最近的发现:研究中使用了28项患者报告的结果和经验测量。这些研究主要使用患者报告的结局指标来评估症状负担和痛苦。只有四项研究同时使用了患者报告的结果测量和患者报告的经历测量。大多数研究主要包括癌症患者。在过去的18个月里,只发现了一项新的措施。在住院姑息治疗中,缺乏使用电子版的患者报告的结果和经验措施。摘要:在姑息治疗中使用电子版患者报告的结果和患者报告的经验措施的证据有限。在医院为基础的专科姑息治疗中,迫切需要加强对更全面的患者报告结果措施的理解和常规实施。需要进一步的研究来确定在这些环境中使用的患者报告的整体结果测量和患者报告的经验测量的最合适的电子版本。
{"title":"Patient-reported and patient experience outcome tools for palliative care in acute hospitals - What's helpful? What are we missing?","authors":"Bridget Johnston, Muzeyyen Seckin, Alison Brown","doi":"10.1097/SPC.0000000000000785","DOIUrl":"10.1097/SPC.0000000000000785","url":null,"abstract":"<p><strong>Purpose of the review: </strong>The primary aim of this review was to identify and describe the tools or methods used to capture patient-reported experiences and outcomes related to palliative care provided within acute hospital settings.</p><p><strong>Recent findings: </strong>Twenty-eight patient-reported outcome and experience measures were used across the studies. The studies mainly used the patient-reported outcome measures to assess symptom burden and distress. Only four studies used both patient-reported outcome measures and patient-reported experience measures. Most studies predominantly included patients with cancer. Only one new measure was found in the last 18 months. There was lack of use of electronic versions of patient-reported outcome and experience measures in inpatient palliative care.</p><p><strong>Summary: </strong>Limited evidence was found on the use of electronic version of patient-reported outcome and patient reported experience measures in inpatient palliative care. There is a critical need to enhance understanding and routine implementation of more holistic patient-reported outcome measures in hospital-based specialist palliative care. Further research is needed to identify the most appropriate electronic version of holistic patient-reported outcome measures and patient-reported experience measures for use in these settings.</p>","PeriodicalId":48837,"journal":{"name":"Current Opinion in Supportive and Palliative Care","volume":" ","pages":"215-228"},"PeriodicalIF":2.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145349382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Social isolation and loneliness in serious illness: what Compassionate Communities can offer. 严重疾病中的社会隔离和孤独:富有同情心的社区可以提供什么。
IF 2 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-01 Epub Date: 2025-10-28 DOI: 10.1097/SPC.0000000000000777
Elaine Stevens

Purpose of the review: Social isolation and loneliness are common in people with advanced illness. This leads to reduced quality of life and all-cause mortality. The aim of this review is to identify the causes of social isolation in those with serious illness and consider the role of Public Health Palliative Care (PHPC) and Compassionate Communities in reducing these insidious issues.

Recent findings: Recent studies have expanded the evidence base around the causes of social isolation in those with serious illness. While there has been a plethora of research on the outcomes of Compassionate Communities initiative recent research has identified that more needs to be done to evidence their effectiveness and efficiency.

Summary: Social isolation and loneliness in those with serious illness have a negative effect on the quality of life. However, much still needs to be done to improve this situation in an effective and efficient way that meet the needs of individuals. It would appear that PHPC, and in particular Compassionate Communities, have a key role to play in this endeavour.

综述目的:社会隔离和孤独感在晚期疾病患者中很常见。这导致生活质量和全因死亡率下降。本综述的目的是确定严重疾病患者社会隔离的原因,并考虑公共卫生姑息治疗(PHPC)和富有同情心的社区在减少这些潜在问题方面的作用。最近的发现:最近的研究扩大了严重疾病患者社会孤立原因的证据基础。虽然对富有同情心的社区倡议的结果进行了大量研究,但最近的研究表明,需要做更多的工作来证明其有效性和效率。总结:严重疾病患者的社会隔离和孤独感对生活质量有负面影响。但是,仍需要做许多工作,以有效和有效率的方式改善这种情况,以满足个人的需要。看来PHPC,特别是富有同情心的社区,在这一努力中发挥着关键作用。
{"title":"Social isolation and loneliness in serious illness: what Compassionate Communities can offer.","authors":"Elaine Stevens","doi":"10.1097/SPC.0000000000000777","DOIUrl":"10.1097/SPC.0000000000000777","url":null,"abstract":"<p><strong>Purpose of the review: </strong>Social isolation and loneliness are common in people with advanced illness. This leads to reduced quality of life and all-cause mortality. The aim of this review is to identify the causes of social isolation in those with serious illness and consider the role of Public Health Palliative Care (PHPC) and Compassionate Communities in reducing these insidious issues.</p><p><strong>Recent findings: </strong>Recent studies have expanded the evidence base around the causes of social isolation in those with serious illness. While there has been a plethora of research on the outcomes of Compassionate Communities initiative recent research has identified that more needs to be done to evidence their effectiveness and efficiency.</p><p><strong>Summary: </strong>Social isolation and loneliness in those with serious illness have a negative effect on the quality of life. However, much still needs to be done to improve this situation in an effective and efficient way that meet the needs of individuals. It would appear that PHPC, and in particular Compassionate Communities, have a key role to play in this endeavour.</p>","PeriodicalId":48837,"journal":{"name":"Current Opinion in Supportive and Palliative Care","volume":" ","pages":"229-233"},"PeriodicalIF":2.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145070899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Opinion in Supportive and Palliative Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1